Barclays PLC Acquires 83,412 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Barclays PLC increased its holdings in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 449.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 101,953 shares of the company’s stock after acquiring an additional 83,412 shares during the period. Barclays PLC owned about 0.12% of Stereotaxis worth $208,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Jane Street Group LLC grew its holdings in Stereotaxis by 26.9% during the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock valued at $61,000 after purchasing an additional 6,313 shares during the period. State Street Corp lifted its position in shares of Stereotaxis by 5.7% during the third quarter. State Street Corp now owns 680,612 shares of the company’s stock worth $1,388,000 after acquiring an additional 36,518 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Stereotaxis by 10.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock worth $341,000 after acquiring an additional 15,491 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Stereotaxis during the third quarter worth $39,000. Finally, Renaissance Technologies LLC lifted its position in shares of Stereotaxis by 46.2% during the second quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock worth $889,000 after acquiring an additional 154,400 shares in the last quarter. 45.35% of the stock is owned by institutional investors.

Stereotaxis Trading Up 11.4 %

Shares of STXS stock opened at $2.64 on Tuesday. Stereotaxis, Inc. has a 52-week low of $1.66 and a 52-week high of $3.29. The firm has a market capitalization of $223.69 million, a P/E ratio of -9.43 and a beta of 1.57.

Stereotaxis (NYSEAMERICAN:STXS) last issued its quarterly earnings results on Monday, November 11th. The company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.03). Stereotaxis had a negative return on equity of 162.54% and a negative net margin of 85.79%. The firm had revenue of $9.20 million for the quarter, compared to the consensus estimate of $6.80 million. On average, analysts predict that Stereotaxis, Inc. will post -0.26 EPS for the current year.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.